Biblio

Export 792 results:
[ Author(Desc)] Title Type Year
Filters: Keyword is Humans  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
O
R. O'Caoimh, Timmons, S., and D Molloy, W., Screening for Mild Cognitive Impairment: Comparison of "MCI Specific" Screening Instruments., J Alzheimers Dis, vol. 51, no. 2, pp. 619-29, 2016.
E. Oldoni, Fumagalli, G. G., Serpente, M., Fenoglio, C., Scarioni, M., Arighi, A., Bruno, G., Talarico, G., Confaloni, A., Piscopo, P., Nacmias, B., Sorbi, S., Rainero, I., Rubino, E., Pinessi, L., Binetti, G., Ghidoni, R., Benussi, L., Grande, G., Arosio, B., Bursey, D., Kauwe, J. S., Cioffi, S. Mg, Arcaro, M., Mari, D., Mariani, C., Scarpini, E., and Galimberti, D., PRNP P39L Variant is a Rare Cause of Frontotemporal Dementia in Italian Population., J Alzheimers Dis, vol. 50, no. 2, pp. 353-7, 2016.
R. Olmos-Villaseñor, Sepulveda-Silva, C., Julio-Ramos, T., Fuentes-Lopez, E., Toloza-Ramirez, D., Santibañez, R. A., Copland, D. A., and Mendez-Orellana, C., Phonological and Semantic Fluency in Alzheimer's Disease: A Systematic Review and Meta-Analysis., J Alzheimers Dis, vol. 95, no. 1, pp. 1-12, 2023.
N. L. Olson and Albensi, B. C., Dementia-Friendly "Design": Impact on COVID-19 Death Rates in Long-Term Care Facilities Around the World., J Alzheimers Dis, vol. 81, no. 2, pp. 427-450, 2021.
B. Ongali, Nicolakakis, N., Tong, X. - K., Aboulkassim, T., Imboden, H., and Hamel, E., Enalapril Alone or Co-Administered with Losartan Rescues Cerebrovascular Dysfunction, but not Mnemonic Deficits or Amyloidosis in a Mouse Model of Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 4, pp. 1183-95, 2016.
R. Ono, Sakurai, T., Sugimoto, T., Uchida, K., Nakagawa, T., Noguchi, T., Komatsu, A., Arai, H., and Saito, T., Mortality Risks and Causes of Death by Dementia Types in a Japanese Cohort with Dementia: NCGG-STORIES., J Alzheimers Dis, vol. 92, no. 2, pp. 487-498, 2023.
M. Ángel Ontiveros-Torres, Labra-Barrios, M. Luisa, Díaz-Cintra, S., Aguilar-Vázquez, A. Ruth, Moreno-Campuzano, S., Flores-Rodríguez, P., Luna-Herrera, C., Mena, R., Perry, G., Florán-Garduño, B., Luna-Muñoz, J., and Luna-Arias, J. Pedro, Fibrillar Amyloid-β Accumulation Triggers an Inflammatory Mechanism Leading to Hyperphosphorylation of the Carboxyl-Terminal End of Tau Polypeptide in the Hippocampal Formation of the 3×Tg-AD Transgenic Mouse., J Alzheimers Dis, vol. 52, no. 1, pp. 243-69, 2016.
N. Ortí-Casañ, Wajant, H., H Kuiperij, B., Hooijsma, A., Tromp, L., Poortman, I. L., Tadema, N., de Lange, J. H. E., Verbeek, M. M., De Deyn, P. P., Naudé, P. J. W., and Eisel, U. L. M., Activation of TNF Receptor 2 Improves Synaptic Plasticity and Enhances Amyloid-β Clearance in an Alzheimer's Disease Mouse Model with Humanized TNF Receptor 2., J Alzheimers Dis, vol. 94, no. 3, pp. 977-991, 2023.
M. C. de Olive Otto, H Y Wu, J., Thacker, E. L., Lai, H. Tsz Mung, Lemaitre, R. N., Padhye, N., Song, X., King, I. B., Lopez, O., Siscovick, D. S., and Mozaffarian, D., Circulating Omega-3 and Omega-6 Fatty Acids, Cognitive Decline, and Dementia in Older Adults., J Alzheimers Dis, vol. 95, no. 3, pp. 965-979, 2023.
A. Oulhaj, Jernerén, F., Refsum, H., A Smith, D., and de Jager, C. A., Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment., J Alzheimers Dis, vol. 50, no. 2, pp. 547-57, 2016.
S. V. Ovsepian and O'Leary, V. B., Neuronal activity and amyloid plaque pathology: an update., J Alzheimers Dis, vol. 49, no. 1, pp. 13-9, 2016.
P
M. Pacheco Pachado, Casas, A. I., Elbatreek, M. H., Nogales, C., Guney, E., Espay, A. J., and Schmidt, H. H. H. W., Re-Addressing Dementia by Network Medicine and Mechanism-Based Molecular Endotypes., J Alzheimers Dis, vol. 96, no. 1, pp. 47-56, 2023.
M. Pacheco-Herrero, Soto-Rojas, L. O., Reyes-Sabater, H., Garcés-Ramirez, L., López, Fde la Cruz, Villanueva-Fierro, I., and Luna-Muñoz, J., Current Status and Challenges of Stem Cell Treatment for Alzheimer's Disease., J Alzheimers Dis, vol. 84, no. 3, pp. 917-935, 2021.
E. L. Paley, Merkulova-Rainon, T., Faynboym, A., Shestopalov, V. I., and Aksenoff, I., Geographical Distribution and Diversity of Gut Microbial NADH:Ubiquinone Oxidoreductase Sequence Associated with Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 4, pp. 1531-1540, 2018.
R. F. Palmer and Royall, D. R., Future Dementia Severity is Almost Entirely Explained by the Latent Variable δ's Intercept and Slope., J Alzheimers Dis, vol. 49, no. 2, pp. 521-9, 2016.
Y. Pan, Liu, R., Terpstra, E., Wang, Y., Qiao, F., Wang, J., Tong, Y., and Pan, B., Dysregulation and diagnostic potential of microRNA in Alzheimer's disease., J Alzheimers Dis, vol. 49, no. 1, pp. 1-12, 2016.
V. Panzarella, Mauceri, R., Baschi, R., Maniscalco, L., Campisi, G., and Monastero, R., Oral Health Status in Subjects with Amnestic Mild Cognitive Impairment and Alzheimer's Disease: Data from the Zabút Aging Project., J Alzheimers Dis, vol. 87, no. 1, pp. 173-183, 2022.
S. G. Papageorgiou, Voskou, P., Economou, A., Beratis, I., and Douzenis, A., Testamentary Capacity Assessment Tool (TCAT): A Brief Instrument for Patients with Dementia., J Alzheimers Dis, vol. 61, no. 3, pp. 985-994, 2018.
Y. Shin Park, Joo, H. Jin, Jang, Y. Seo, Jeon, H., Park, E. - C., and Shin, J., Socioeconomic Status and Dementia Risk Among Intensive Care Unit Survivors: Using National Health Insurance Cohort in Korea., J Alzheimers Dis, vol. 97, no. 1, pp. 273-281, 2024.
M. A. Parra, Barriers to Effective Memory Assessments for Alzheimer's Disease., J Alzheimers Dis, vol. 90, no. 3, pp. 981-988, 2022.
F. Pasquier, Sadowsky, C., Holstein, A., Leterme, G. Le Prince, Peng, Y., Jackson, N., Fox, N. C., Ketter, N., Liu, E., and J Ryan, M., Two Phase 2 Multiple Ascending-Dose Studies of Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Mild-to-Moderate Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 4, pp. 1131-43, 2016.

Pages